NLRP3 and diabetic kidney disease: (+)-Catechin also suppresses NLRP3-associated inflammation in the kidney, as demonstrated by reductions in NLRP3, ASC, AIM2, caspase 1, IL-1β, and IL-18 expression in mice with diabetic nephropathy and palmitic acid-treated HK-2 cells.